Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02733055 · ClinicalTrials.gov registry record · NA

Posturography as Biomarker of Oculomotor and Postural Control Integration

A NA study of Postural Balance, sponsored by Carrick Institute for Graduate Studies.

Completed
Registry status
NA
Development phase
150
Enrollment target
2
Study locations

NCT02733055 is a NA study of Postural Balance that has completed, run by Carrick Institute for Graduate Studies. The registered enrollment target is 150 participants, above the 81-participant average among 8 other Postural Balance trials with a reported enrollment target (85% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02733055, a NA study of Postural Balance, has completed, sponsored by Carrick Institute for Graduate Studies.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
2
Study locations

Study Summary

Determine the effects looking in certain direction or moving the eyes in a certain way have on the ability of a subject to maintain equilibrium in different circumstances (eyes open/closed, and standing on hard or compliant surface, with the head straight or rotated right or left, flexed or extended).

Conditions Studied

Interventions

  • OTHER posturographic evaluation

Study Locations (2)

Georgia

  • Carrick Institute for Graduate Studies - Atlanta

Victoria

  • Carrick Institute for Graduate Studies - Hampton

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2016-04-01
Est. Completion 2019-04-12
Phase NA

What the Registry Record Tells You About NCT02733055

The ClinicalTrials.gov registry entry for NCT02733055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 81-participant average among 8 other Postural Balance trials with a reported enrollment target (85% higher). The listed sponsor is Carrick Institute for Graduate Studies, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postural Balance appearing as the primary indexed condition, and to 1 intervention - of which posturographic evaluation is the first listed.

NCT02733055 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Victoria.

Frequently Asked Questions

What is clinical trial NCT02733055 about?

NCT02733055 is a clinical study titled "Posturography as Biomarker of Oculomotor and Postural Control Integration". Determine the effects looking in certain direction or moving the eyes in a certain way have on the ability of a subject to maintain equilibrium in different circumstances (eyes open/closed, and standing on hard or compliant surface, with the head straight or rotated right or left, flexed or extended...

What is the current status of trial NCT02733055?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2016-04-01. Estimated completion is 2019-04-12.

What conditions does trial NCT02733055 study?

This clinical trial studies the following conditions: Postural Balance.

What interventions are being tested in trial NCT02733055?

The interventions under investigation include: posturographic evaluation (OTHER).

Who is sponsoring clinical trial NCT02733055?

This trial is sponsored by Carrick Institute for Graduate Studies, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02733055 being conducted?

This trial has 2 study locations across Georgia, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postural Balance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.